Your Catalyst To a Lucrative Business
Genital warts, HPV, HIV, and hepatitis genital herpes are examples of STIs caused by viruses. These microorganisms get transmitted through semen, blood, and vaginal fluids. Chlamydia is by far the most commonly occurring sexually transmitted disease. In terms of revenues, this segment held the highest share in the overall industry. It generated revenues surpassing USD 36 billion in 2016. However, rising cases of syphilis may contribute to more than 20 % of total industry revenues over the forecast period( 2016 to 2024). Based on location of tests, the market is bifurcated into laboratory testing and point of care( PoC) testing. Laboratory tests are carried out either in public health labs or in private / commercial labs. Unlike, PoC testing solutions, laboratory tests deliver more precise results. PoC tests( such as test kits) are a more convenient option because these deliver immediate results, but they are not always accurate. The introduction of bedside & mobile testing is a step towards enhanced healthcare. The industry for bedside & mobile testing may expand at a CAGR nearly 10 % from 2016 to 2024.
According to type of device, the worldwide STD diagnostics market is segmented into thermal cyclers- PCRs, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate reader, phone chips( microfluidics + ICT), and bench top / portable / rapid diagnostics kits. Portable / rapid diagnostics and phone chips are PoC testing devices, while the others are laboratory test devices. The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8 % during the forecast period. The portable PoC testing devices industry is propelled by continuous technological innovations. It may generate revenues exceeding USD 46 billion by 2024.
Geographically, the global STD diagnostics market is divided into Asia Pacific, North Amer ica, Latin America, Europe, and the Middle East & Africa. Driven by surging public awareness about STIs and the presence of a well developed system of health insurance, North America dominates the global industry. Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices. As per ongoing industry trends, Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run. Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation, Abbott Laboratories, BioMerieux, Roche Holdings AG, and Becton Dickinson & Company.
Recently, QuantuMDx, a U. K. based company dealing in life sciences diagnostics & tools, developed the Q- Poc. This is a highly affordable diagnostic DNA analyzer which is commonly known as the“ handheld lab”. It is capable of diagnosing certain types of cancers and a number of infectious diseases( including the sexually transmitted ones). Equipped with a solar battery, the Q-Poc can analyze biological samples, for example, swabs are used to detect sexually transmitted diseases / infections. Browse Related Category Market Reports @ https:// www. hexaresearch. com / research-category / clinicaldiagnostics-industry
Follow Us: